/PRNewswire/ Celdara Medical, LLC ("Celdara") announced today the addition of Antonito T. Panganiban, PhD, to the Pandemic Security Initiative s Scientific.
CAMBRIDGE, Mass.and LEBANON, N.H. and NEW YORK, Aug. 11, 2021 /PRNewswire/ Celdara Medical, LLC ("Celdara") announced today the addition of Antonito T. Panganiban, PhD, to the Pandemic Security Initiative s
Celdara Medical and the University of Vermont Secure NIH Funding to Improve Pandemic Preparedness and Response
News provided by
Share this article
Share this article
CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Jan. 19, 2021 /PRNewswire/ Celdara Medical, LLC ( Celdara ) today announced that the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) has awarded it a two-year Small Business Technology Transfer Research (STTR) grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic against RNA viruses, including SARS-CoV-2, SARS, Ebola, influenza, and pathogenic arenaviruses. This project builds on the discoveries of Principal Investigator Jason Botten, a professor at the University of Vermont s Larner College of Medicine in Burlington, Vt. Dr. Botten is also scientific founder of Celdara, and a founding member of Celdara s Pandemic Security Initiative Scientific Advisory Board.